Silver Book Fact

Prescription eye drops could delay or prevent half of glaucoma cases in African Americans.

Higginbotham, Eve J., Mae O. Gordon, Julie A. Beiser, Michael V. Drake, G. Richard Bennett, M. Roy Wilson, and Michael A. Kass. The Ocular Hypertension Treatment Study: Topical medication delays or prevents primary open-angle glaucoma in African American individuals. Archives of Ophthalmology. 2004; 122(6): 813-20. http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=15197055&dopt=AbstractPlus

Reference

Title
The Ocular Hypertension Treatment Study: Topical medication delays or prevents primary open-angle glaucoma in African American individuals
Publication
Archives of Ophthalmology
Publication Date
2004
Authors
Higginbotham, Eve J., Mae O. Gordon, Julie A. Beiser, Michael V. Drake, G. Richard Bennett, M. Roy Wilson, and Michael A. Kass
Volume & Issue
Volume 122, Issue 6
Pages
813-20
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Detection and treatment of proliferative diabetic eye disease and clincally significant macular edema with laser therapy can reduce severe vision loss progression by 50% to 60%  
  • Anti-VEGF Visual Improvement
    Nearly 50% of DME patients who received an anti-VEGF drug, experienced substantial visual improvement after a year of injections.  
  • After 9 years of tight blood pressure control, patients with type 2 diabetes had a 34% reduction in retinopathy progression and a 47% reduction in risk of visual acuity deterioration…  
  • Impact of a healthy lifestyle on age-related macular degeneration (AMD)
    A study exploring the impact of a healthy lifestyle on age-related macular degeneration (AMD) found that women whose diets were the healthiest (scored on the 2005 Healthy Eating Index) had…  
  • Because the resource use and direct cost of glaucoma treatment and management increases as the disease severity worsens– from an average $623 per early-stage patient to $2,511 per late-stage patient–…